Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy.
Nishikura T, Yamamoto K, Wakabayashi K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Onishi Y, Hibi K, Kawai K, Murakami T, Takasaki A, Higashitani N, Nakano M, Ono K, Kimura T; STOPDAPT-3 investigators.
Nishikura T, et al. Among authors: nakano m.
JACC Asia. 2025 Nov 13:S2772-3747(25)00542-3. doi: 10.1016/j.jacasi.2025.09.015. Online ahead of print.
JACC Asia. 2025.
PMID: 41307518
Free article.